Syed M. Shah
42 Papers
307 Citations
Syed M. Shah is an academic researcher. The author has contributed to research in topics: Dosage form & Tazobactam. The author has an hindex of 10, co-authored 42 publications.
Chat about Author
Papers
Patent
Novel succinate salt of O-desmethyl-venlafaxine
Anthony Francis Hadfield,Syed M. Shah,Michael William Winkley,Karen Wiggins Sutherland,James Andrew Provost,Aeri Park,Rex Alwyn Shipplett,Brenton William Russell,Beat Theodor Weber +8 more
- 11 Feb 2002
TL;DR: In this paper, a novel salt of O-desmethyl venlafaxine is provided, Odesmethylvenlafe succinate, and pharmaceutical compositions, dosage forms and methods of use are also provided.
74
Patent
Compositions containing piperacillin and tazobactam useful for injection
Jonathan Marc Cohen,Syed M. Shah,Christian Ofslager,Mahdi B. Fawzi +3 more
- 07 Apr 2004
TL;DR: An aminocarboxylic acid chelating agent, preferably EDTA, or a salt thereof has been found to be useful for inhibiting particulate formation in piperacillin/tazobactam parenteral combinations.
53
Patent
Formulations for parenteral delivery of compounds and uses thereof
Syed M. Shah,Christian Ofslager,Mahdi B. Fawzi,Natalyia Bazhina +3 more
- 03 Aug 2007
TL;DR: In this paper, the authors present formulations that achieve effective delivery of methylnaltrexone compositions, which are useful for preventing, treating delaying, diminishing or reducing the severity of side effects resulting from use of analgesic opioids.
27
Patent
Peripheral opioid receptor antagonists, and uses thereof
Nataliya Bazhina,George Joseph Donato,Steven R. Fabian,John Lokhnauth,Sreenivasulu Megati,Charles K Melucci,Christian Ofslager,Niketa Patel,Galen Radebaugh,Syed M. Shah,Jan Szeliga,Huyi Zhang,Tianmin Zhu +12 more
- 30 Sep 2009
TL;DR: In this article, the present invention provides a compound of formula I: where X −, R 1, and R 2 are as defined herein, and compositions thereof, and X −, R 1, and R 1 are compositions thereof.
23
Patent
Bazedoxifene acetate formulations
Syed M. Shah,Diorio Christopher R,Ehrnsperger Eric C,Kadum A. Ali +3 more
- 23 Aug 2006
TL;DR: Bazedoxifene acetate formulations and compositions have improved properties relating to reduction, elimination, or prevention of polymorphic conversion of bazedoxefeneacetate as discussed by the authors.
13